https://sanacurrents.com/contravir-releases-data-on-hcc-study/ 2018-05-30T00:37:50+00:00 https://sanacurrents.com/crispr-vertex-sickle-cell-drug-ind-faces-questions-from-fda/ 2018-05-30T02:05:28+00:00 https://sanacurrents.com/curis-cancer-drug-receives-fast-track-designation-from-fda/ 2018-06-01T23:01:22+00:00 https://sanacurrents.com/market-response-driven-by-preliminary-nktr-214-data/ 2018-06-20T04:09:01+00:00 https://sanacurrents.com/j-j-expected-to-continue-developing-gerons-imetelstat/ 2018-08-30T01:46:20+00:00 https://sanacurrents.com/recro-pharma-reveals-resubmission-plan-for-pain-med-candidate/ 2018-09-07T19:51:52+00:00 https://sanacurrents.com/molecular-templates-and-takeda-agree-to-development-deal/ 2018-09-28T06:14:27+00:00 https://sanacurrents.com/fda-tells-evoke-to-regroup-for-one-last-dance-3/ 2019-03-05T18:46:48+00:00 https://sanacurrents.com/catalysts-stand-tall-in-down-market/ 2020-10-08T20:27:06+00:00 https://sanacurrents.com/wp-content/uploads/2020/09/blog4.png https://sanacurrents.com/proteostasis-reports-positive-early-stage-data-on-cystic-fibrosis-candidates/ 2020-10-08T20:28:54+00:00 https://sanacurrents.com/wp-content/uploads/2020/09/blog1.png https://sanacurrents.com/selecta-biosciences-trading-picks-up-after-mma-101-designation-and-askbio-buyout/ 2020-10-29T21:37:33+00:00 https://sanacurrents.com/epizyme-resolves-clinical-hold/ 2020-11-14T22:37:54+00:00 https://sanacurrents.com/reata-gains-orphan-status-in-europe-for-rare-kidney-disease-drug/ 2020-11-14T22:38:46+00:00 https://sanacurrents.com/big-pharma-steps-up-to-antimicrobial-resistance-2/ 2020-11-18T22:46:41+00:00 https://sanacurrents.com/turning-point-trial-records-positive-results-matinas-drug-does-not-prove-superiority/ 2021-02-01T16:12:52+00:00 https://sanacurrents.com/talaris-tals-reports-positive-data-for-kidney-transplant-drug-fcr001/ 2021-11-05T00:28:04+00:00 https://sanacurrents.com/codiak-cdak-to-report-early-exosting-data-sanacurrents-closing-coverage/ 2021-11-09T00:32:21+00:00 https://sanacurrents.com/krystal-soars-on-compelling-b-vec-data/ 2021-11-29T20:30:50+00:00 https://sanacurrents.com/wp-content/uploads/2021/11/KRYS.png https://sanacurrents.com/sanacurrents-discontinuing-coverage-of-summit-therapeutics/ 2023-06-21T13:55:20+00:00 https://sanacurrents.com/sanacurrents-closing-coverage-on-verrica-vrca-viridian-vrdn-2/ 2023-07-13T22:36:53+00:00 https://sanacurrents.com/fda-approval-for-tarsus-tars-eye-drug-yields-big-gain-on-sanacurrents-biotech-catalyst/ 2023-07-25T16:33:06+00:00 https://sanacurrents.com/cardiffs-crdf-shares-soar-on-new-onvansertib-deal-with-pfizer/ 2023-08-08T23:23:28+00:00 https://sanacurrents.com/will-sickle-cell-drug-reach-patients/ 2023-08-15T22:16:08+00:00 https://sanacurrents.com/picture-perfect-phase-iii-data-pushes-crinetics-crnx-shares-up-63/ 2023-09-12T01:38:11+00:00 https://sanacurrents.com/coya-therapeutics-coya-reports-positive-biomarker-data-in-als/ 2023-09-13T20:52:08+00:00 https://sanacurrents.com/astrazeneca-snaps-up-fusion-for-2-4-billion/ 2024-03-19T23:19:06+00:00 https://sanacurrents.com/bids-for-verona-vrna-monogram-mgrm-may-signal-new-life-for-ma/ 2025-07-17T21:07:40+00:00 https://sanacurrents.com/buyout-candidates-thrive-rare-disease-drug-candidates-dive/ 2025-10-29T19:30:49+00:00